— Know what they know.
Not Investment Advice
Also trades as: GSK (NYSE) · $vol 208M · GSK.L (LSE) · $vol 186M · GS7.DE (XETRA) · $vol 2M

GLAXF Earnings

GSK plc
1W: +5.6% 1M: +7.1% 3M: -1.7% YTD: +11.5% 1Y: +21.0% 3Y: +61.5% 5Y: +30.3%
$26.12
+1.22 (+4.90%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 60 · $104.7B mcap · 3.88B float · 0.0000% daily turnover · Short 54% of daily vol
Credit Risk of going bust: lower than 78% of companies Debt: 19.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.42 (down 98%), GSK plc would be worth roughly what it owes.
Total debt $24.13B against a stock market value of $102.18B.
Distance to default 9.19 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $14.90B (short-term plus half of long-term), stock volatility 25.7%; Altman Z'' 1.49. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Last Earnings 2026-07-29
EPS
£0.67 (US$0.89)
▲ Beat +8.6%
Revenue
£11.1B ($14.8B)
▲ Beat +1.9%
EPS Beat Streak: 3 quarters
Next Earnings 2026-10-28
EPS Estimate
£0.74 (US$0.98)
Range: £0.73 - £0.75
Revenue Estimate
£16.5B ($22.0B)
1 analysts
1 USD = 0.75 GBP

Estimate vs Actual

Earnings Surprise History

16/19
EPS Beats
12/19
Revenue Beats
84%
EPS Beat Rate
63%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-26 annual 2030-12-31 £2.21 £2.21 — £38,342,192,112 £38,284,930,774
2026-10-26 annual 2026-12-31 £1.82 £1.82 — £34,385,656,399 £34,334,303,865
2026-10-26 quarter 2027-03-30 £0.52 £0.51 ▼ 0.01 £8,240,547,571 £8,228,240,899
2026-10-26 annual 2027-12-31 £1.92 £1.92 — £35,943,049,132 £35,889,370,743
2026-10-26 quarter 2027-12-30 £0.32 £0.32 — £9,367,026,364 £9,353,037,376
2026-10-26 quarter 2027-06-30 £0.52 £0.52 — £8,874,826,171 £8,861,572,249
2026-10-26 annual 2028-12-31 £2.02 £2.02 — £37,186,668,370 £37,131,132,724
2026-10-26 quarter 2027-09-30 £0.60 £0.60 — £9,351,803,678 £9,337,837,424
2026-10-26 quarter 2026-12-30 £0.31 £0.31 — £9,102,405,402 £9,088,811,607
2026-10-26 annual 2029-12-31 £2.17 £2.17 — £38,632,257,484 £38,574,562,954
2026-10-23 annual 2028-12-31 £2.02 £2.02 — £37,136,686,288 £37,186,668,370
2026-10-23 annual 2029-12-31 £2.17 £2.17 — £38,580,332,407 £38,632,257,484
2026-10-23 quarter 2027-03-30 £0.51 £0.52 ▲ 0.01 £8,229,471,566 £8,240,547,571
2026-10-23 quarter 2027-12-30 £0.32 £0.32 — £9,354,436,275 £9,367,026,364
2026-10-23 annual 2027-12-31 £1.92 £1.92 — £35,894,738,582 £35,943,049,132
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms